pre-IPO PHARMA

COMPANY OVERVIEW

Galvanize Therapeutics aims to become the global leader in delivering medical technology innovations that drive biologic processes to treat a range of diseases, starting with treating chronic bronchitis symptoms, cardiac arrhythmias, and solid tumors. Formed by ATP (Apple Tree Partners) in 2022, Galvanize is based in San Carlos, Calif., and is researching and commercializing its revolutionary Aliya Pulsed Electric Field (PEF) energy platform in the United States and Europe.


LOCATION

  • San Carlos, CA, USA

  • THERAPEUTIC AREAS

  • Cardiovascular Disease
  • Respiratory Disease

  • WEBSITE

    https://www.galvanizetherapeutics.com/


    CAREER WEBSITE

    https://galvanizetx.com/careers/


    SOCIAL MEDIA


    INVESTORS

    apple-tree-partners fidelity-management-research-company gilmartin-capital intuitive-surgical


    PRESS RELEASES


    Nov 10, 2022

    Galvanize Therapeutics Presents Clinical Data Using Pulsed Electric Field (PEF) Energy for Non-Small Cell Lung Cancer


    Sep 15, 2022

    Galvanize Therapeutics Announces Merger to Create the Premier Pulsed Electric Field Therapy Company and Completion of $100 Million Series B Financing USA - English España - español France - Français Deutschland - Deutsch


    For More Press Releases


    Google Analytics Alternative